Polycaprolactone-based fibers and implants including same
A polymeric material fiber includes a polymeric material which is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers. An implantable mesh includes this fiber alone or combined with one or more additional fiber materials. Methods for treating patients involve implanting the fiber material, for example incorporated in a mesh.
1. A melt extruded, oriented polymeric material fiber, wherein the polymeric material is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers; and wherein:
(i) the polymeric material fiber has a tensile strength of about 450 MPa to about 650 MPa; and
(ii) the polymeric material fiber has an elongation at break in the range of 45% to 65%.
2. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material has been stress hardened by stretching.
3. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material fiber has an elastic modulus in the range of 750 MPa to 1200 MPa.
4. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material fiber has a tensile strength in the range of about 500 MPa to about 650 MPa.
5. The melt extruded, oriented polymeric material fiber of claim 1 , which has been prepared by a method comprising melt extruding the polymeric material to form an extrudate, allowing the extrudate dwell time to crystallize, and drawing the extrudate.
6. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material fiber has an average diameter in the range of about 0.01 to about 0.4 mm.
7. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material fiber has a crystallinity in the range of 35% to 50%.
8. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the homopolymer or the copolymer is a linear polymer.
9. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the tensile strength of the fiber, as measured after immersion in phosphate buffered physiological saline for 60 minutes, decreases less than 20% after immersion in phosphate buffered physiological saline for 6 months.
10. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material is a homopolymer of caprolactone.
11. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the polymeric material is a copolymer of at least 90% by weight of caprolactone and one or more additional monomers.
12. The melt extruded, oriented polymeric material fiber of claim 1 , wherein the number average molecular weight of the homopolymer or the copolymer is in the range of about 10000 to about 150000 kDa.
13. The melt extruded, oriented polymeric material fiber of claim 1 , which has been sterilized.
14. A medical device comprising one or more melt extruded, oriented polymeric fibers according to claim 1 .
15. The medical device of claim 14 , wherein the device is a medical textile, tube, surgical mesh, hernia mesh, breast reconstruction mesh, mastopexy mesh, pericardial patch, anti-adhesion patch, cardiovascular patch, guided tissue regeneration patch, sling, monofilament suture, multifilament suture, ligament repair device, tendon repair device, meniscus repair device, cartilage repair device, nerve guide, stent, vascular graft, or dura repair device.
16. A medical device according to claim 15 , further comprising a decellularized extracellular matrix tissue.
17. A method for making a melt extruded, oriented polymeric material fiber, comprising:
melt extruding a polymeric material which is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers, to form an extrudate;
solidifying the extrudate by cooling the polymeric material; and
drawing the extrudate so as to stretch harden the polymeric material, wherein the polymeric material fiber has a tensile strength of about 450 MPa to about 650 MPa, and the polymeric material fiber has an elongation at break in the range of 45% to 65%.
18. The method of claim 17 , wherein said drawing elongates the extrudate by at least 600%.
19. An implantable medical mesh product, comprising:
a mesh structure comprised of woven and/or knit fibers, wherein the fibers include at least one melt extruded, oriented polymeric material fiber, wherein the polymeric material is a homopolymer of caprolactone or a copolymer of at least 90% by weight of caprolactone and one or more additional monomers; and
wherein the polymeric material fiber has a tensile strength of about 450 MPa to about 650 MPa, and the polymeric material fiber has an elongation at break in the range of 45% to 65%.
20. The implantable medical mesh product of claim 19 , wherein the mesh structure is connected to at least one sheet of a decellularized extracellular matrix tissue.
21. The implantable medical mesh product of claim 19 , wherein the mesh structure is sandwiched between a first sheet of extracellular matrix tissue and a second sheet of extracellular matrix tissue.